The number of patients stopping the medication due to side effects in TRIUMPH-4 were 18.2% on 12 mg, 12.2% on 9 mg, and 4% on placebo
Persistent vomiting, inability to keep food or fluids down, or severe abdominal pain are not expected side effects
Changes in lean body mass with glucagon-like peptide-1-based therapies
And if you're looking for weight loss support yourself, your best first step is always to speak to your GP or registered healthcare professional who can point you in the right direction
GLP-1s in the Real World: What 10+ Years of Prescribing Experience Uncovered (on-demand AMA webinar replay) Key Takeaways GLP-1s can be powerful tools, but they aren't a standalone solution
The combination exists only in theoretical pharmacological analysis and, likely, in unsupervised self-experimentation that produces no publishable data